Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
ZIVO Bioscience, Inc. (ZIVO) had Free Cash Flow of $-5.80M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
$0.01M |
|
$-1.91M |
|
$0.01M |
|
$0.00M |
|
$1.91M |
|
$-1.90M |
|
$-0.01M |
|
$-1.91M |
|
$-1.91M |
|
$-1.91M |
|
$-1.91M |
|
$-1.91M |
|
$-1.91M |
|
$-1.90M |
|
$-1.95M |
|
1.69M |
|
1.69M |
|
$-0.97 |
|
$-0.97 |
|
| Balance Sheet Financials | |
$0.43M |
|
-- |
|
$0.13M |
|
$0.56M |
|
$2.76M |
|
-- |
|
-- |
|
$2.76M |
|
$-2.21M |
|
$-2.21M |
|
$-2.21M |
|
2.38M |
|
| Cash Flow Statement Financials | |
$-5.80M |
|
-- |
|
$4.28M |
|
$1.80M |
|
$0.27M |
|
$-1.52M |
|
$0.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
35.01% |
|
-16072.74% |
|
-16072.75% |
|
-- |
|
-16174.13% |
|
-16174.13% |
|
|
Free Cash Flow |
$-5.80M |
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
3.16 |
|
28.49 |
|
86.52% |
|
86.52% |
|
-343.44% |
|
86.52% |
|
$-0.93 |
|
$-3.43 |
|
$-3.43 |
|